# The Effect of Omalizumab on Allergic Rhinitis Symptoms: a Comparative Study

> **NCT06806826** · PHASE4 · COMPLETED · sponsor: **Yuzuncu Yil University** · enrollment: 50 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Omalizumab

## Key facts

- **NCT ID:** NCT06806826
- **Lead sponsor:** Yuzuncu Yil University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-03-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06806826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06806826, "The Effect of Omalizumab on Allergic Rhinitis Symptoms: a Comparative Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06806826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*